US Patent Issued to SHENZHEN NEPTUNUS PHARMACEUTICAL RESEARCH INSTITUTE on Aug. 19 for "Multi-target tyrosine kinase inhibitor" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,391,706, issued on Aug. 19, was assigned to SHENZHEN NEPTUNUS PHARMACEUTICAL RESEARCH INSTITUTE Co. LTD. (Shenzhen, China).

"Multi-target tyrosine kinase inhibitor" was invented by Shenglin Luan (Shenzhen, China), Tian Tang (Shenzhen, China), Hanmin Huang (Shenzhen, China), Jing Wu (Shenzhen, China), Yidong Feng (Shenzhen, China), Tao Shi (Shenzhen, China), Hanlin Feng (Shenzhen, China) and Lin Yu (Shenzhen, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a multi-target tyrosine kinase inhibitor, which is a compound having protein kinase inhibitory activity as shown in formula (I). The compound is metabolized into a...